Novartis AG Common Stock (NVS)

Financing Cash Flow

$472.20M

TTM · Period ending: · USD

NVS logo

NVS Financing Cash Flow

Latest reported$472.20M
NVS TTM Cash from Financing (-$5.76B → $472.20M)
High-resolution chart · PNG

NVS financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
472,202,394
-2,709,918,281
-14,836,918,281
-19,546,000,000
-17,139,000,000
-15,126,000,000
-11,742,000,000
-9,353,000,000
-9,803,000,000
-10,240,000,000
-14,278,000,000
-17,665,000,000
-21,571,000,000
-20,236,000,000
-20,562,000,000
-19,819,000,000
-16,615,000,000
-17,252,000,000
-16,264,000,000
-15,949,000,000
-12,515,000,000
-11,761,000,000
-2,208,000,000
-475,000,000
-5,088,000,000
-2,931,000,000
-13,627,000,000
-11,971,000,000
-10,879,000,000
-12,381,000,000
-4,244,000,000
-7,093,000,000
-7,409,000,000
-8,891,000,000
-7,733,000,000
-7,640,000,000
-6,045,000,000
-4,675,000,000
-5,314,000,000
-5,786,000,000
-7,640,000,000
-8,448,000,000
-9,176,000,000
-7,143,000,000
-6,027,000,000
-6,215,000,000
-8,147,000,000
-8,923,000,000
-9,235,000,000
-9,116,000,000
-8,769,000,000
-8,395,000,000
-9,120,000,000
-8,273,000,000
-6,675,000,000
-9,751,000,000
-11,394,000,000
-16,279,000,000
-15,024,000,000
-14,864,000,000
-3,900,000,000
3,607,000,000
4,116,000,000
8,035,000,000
1,274,000,000
2,379,000,000
2,809,000,000
-798,000,000
-556,000,000
1,568,000,000
-2,573,000,000
-1,981,000,000
-5,539,000,000
-10,525,000,000
-9,318,000,000
-8,100,000,000
-5,689,000,000
-5,705,000,000
-4,970,000,000
-1,231,000,000
-1,366,000,000
1,103,000,000
-266,000,000
-1,247,000,000
-1,602,000,000
-3,988,000,000
-3,124,000,000
-4,532,000,000
-4,459,000,000
-6,309,000,000
-5,764,000,000
-4,354,000,000
-9,321,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.